Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
50,845
Sort by:
Digital Diabetes Management Market Forecasts to 2034 – Global Analysis By Product (Devices, Software & Platforms, and Services), Device Connectivity, Diabetes Type, Distribution Channel, Deployment Mode, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Digital Diabetes Management Market is accounted for $8.2 billion in 2026 and is expected to reach $24.6 billion by 2034, growing at a CAGR of 14.7% during the...
June 2026
200 pages
Precision Oncology Diagnostics Market Forecasts to 2034 – Global Analysis By Product Type (Companion Diagnostics, Comprehensive Genomic Profiling (CGP), Liquid Biopsy Assays, Single Biomarker Tests, Molecular Diagnostic Tests, Next-Generation Sequencing (NGS)-Based Tests, and Other Product Types), Technology, Biomarker Type, Sample Type, Cancer Type, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Precision Oncology Diagnostics Market is accounted for $8.3 billion in 2026 and is expected to reach $28.6 billion by 2034, growing at a CAGR of 16.7% during t...
June 2026
200 pages
